Clinical trial
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
NCT02819297 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
- Lead sponsor
- Braintree Laboratories
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- June 30, 2017
- Enrollment
- 1,020 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
chronic idiopathic constipation, cic, constipation